Mike Riley, Catalent Biologics: Integrated solutions, better treatments.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Mike Riley, Catalent Biologics: Integrated solutions, better treatments.
Released on: August 20, 2015. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Biologic therapies are transforming the treatment of disease and improving the lives of millions.
  • Summary
  • Transcript
  • Company
Biologic therapies are transforming the treatment of disease and improving the lives of millions. Catalent Biologics partners with leading biologic and biosimilar developers on their next generation of biologics products. Not only aiming to provide flexible, customized solutions to facilitate a streamlined path to the clinic, Mike Riley tells PharmaVentures’ CEO, Fintan Walton how they aim to leverage their unique set of innovative technologies to improve the performance of biologic products.
Biologic therapies are transforming the treatment of disease and improving the lives of millions. Catalent Biologics partners with leading biologic and biosimilar developers on their next generation of biologics products. Not only aiming to provide flexible, customized solutions to facilitate a streamlined path to the clinic, Mike Riley, VP Biologics tells PharmaVentures’ CEO, Fintan Walton how they aim to leverage their unique set of innovative technologies to improve the performance of biologic products.
Catalent
Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.